✦ LIBER ✦
52 POSTER Preclinical development of PTC299: an orally bioavailable small molecule drug that selectively inhibits the production of VEGF protein, tumor growth, and microvessel density
✍ Scribed by T. Davis; L. Cao; N. Tamilarasu; N. Risher; H. Qi; C. Romfo; J. Bombard; J. Sheedy; M. Weetall; Y. Moon
- Book ID
- 118623681
- Publisher
- Elsevier Science
- Year
- 2006
- Tongue
- English
- Weight
- 59 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.